State Street Corp Immunovant, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

A detailed history of State Street Corp transactions in Immunovant, Inc. stock. As of the latest transaction made, State Street Corp holds 2,718,956 shares of IMVT stock, worth $74.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,718,956
Previous 3,641,907 25.34%
Holding current value
$74.8 Million
Previous $118 Million 39.0%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$25.1 - $31.61 $23.2 Million - $29.2 Million
-922,951 Reduced 25.34%
2,718,956 $71.8 Million
Q1 2024

May 15, 2024
BUY
$30.27 - $43.79 $12.9 Million - $18.6 Million
425,531 Added 13.23%
3,641,907 $118 Million
Q4 2023

Feb 14, 2024
SELL
$31.31 - $44.19 $7.9 Million - $11.1 Million
-252,241 Reduced 7.27%
3,216,376 $136 Million
Q3 2023

Nov 14, 2023
BUY
$18.55 - $39.96 $4.35 Million - $9.37 Million
234,448 Added 7.25%
3,468,617 $133 Million
Q2 2023

Aug 14, 2023
SELL
$14.2 - $23.75 $10.4 Million - $17.4 Million
-733,436 Reduced 18.49%
3,234,169 $61.4 Million
Q1 2023

May 15, 2023
BUY
$15.27 - $19.72 $13.1 Million - $16.9 Million
854,662 Added 27.46%
3,967,605 $61.5 Million
Q4 2022

Feb 14, 2023
BUY
$6.59 - $17.75 $14.7 Million - $39.7 Million
2,234,342 Added 254.31%
3,112,943 $55.3 Million
Q3 2022

Nov 15, 2022
SELL
$3.93 - $6.37 $55,330 - $89,683
-14,079 Reduced 1.58%
878,601 $4.9 Million
Q2 2022

Aug 15, 2022
BUY
$3.38 - $5.65 $192,450 - $321,699
56,938 Added 6.81%
892,680 $3.48 Million
Q1 2022

May 16, 2022
SELL
$5.06 - $8.77 $9.85 Million - $17.1 Million
-1,947,052 Reduced 69.97%
835,742 $4.61 Million
Q4 2021

Feb 14, 2022
SELL
$7.33 - $9.32 $9.74 Million - $12.4 Million
-1,329,000 Reduced 32.32%
2,782,794 $23.7 Million
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $1.95 Million - $3.17 Million
-278,843 Reduced 6.35%
4,111,794 $35.7 Million
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $7.28 Million - $13.1 Million
774,877 Added 21.43%
4,390,637 $46.4 Million
Q1 2021

May 17, 2021
BUY
$13.08 - $49.6 $22.8 Million - $86.6 Million
1,746,740 Added 93.46%
3,615,760 $58 Million
Q4 2020

Feb 16, 2021
BUY
$36.36 - $52.71 $26.1 Million - $37.8 Million
717,555 Added 62.32%
1,869,020 $86.3 Million
Q3 2020

Nov 10, 2020
BUY
$22.61 - $38.9 $18.5 Million - $31.9 Million
819,890 Added 247.27%
1,151,465 $40.5 Million
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $4.6 Million - $9.43 Million
331,575 New
331,575 $8.07 Million

Others Institutions Holding IMVT

# of Institutions
220
Shares Held
65.1M
Call Options Held
697K
Put Options Held
629K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email